Tuberculosis trials in Sweden
1 of 3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA randomised, prospective phase II study of pharmacokinetics and safety aspects of higher doses of rifampicin and pyrazinamide in a shortened treatment of mild-to-moderate tuberculosis compared with standard of care
- Where
- Linkoping, Norrkoping
- Age
- 18 years and over
- People
- 40
- Run by
- Region Oestergoetland
See details and how to join2024-518772-32-00 · EU 2024-518772-32-00